Aptevo Therapeutics Inc.·4

Nov 6, 4:47 PM ET

TANG CAPITAL PARTNERS LP 4

4 · Aptevo Therapeutics Inc. · Filed Nov 6, 2020

Insider Transaction Report

Form 4
Period: 2020-11-04
Transactions
  • Purchase

    Common Stock

    [F1][F2]
    2020-11-04$10.63/sh+68,296$725,986391,621 total(indirect: By LP)
  • Purchase

    Common Stock

    [F3][F2]
    2020-11-04$13.11/sh+88,379$1,158,649480,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F4][F2]
    2020-11-04$13.83/sh+160,000$2,212,800640,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F5][F2]
    2020-11-04$13.65/sh+99,854$1,363,007739,854 total(indirect: By LP)
  • Purchase

    Common Stock

    [F6][F2]
    2020-11-04$16.33/sh+60,146$982,184800,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F7][F2]
    2020-11-04$16.84/sh+160,000$2,694,400960,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F8][F2]
    2020-11-05$15.31/sh+160,000$2,449,6001,120,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F9][F2]
    2020-11-05$14.22/sh+77,133$1,096,8311,197,133 total(indirect: By LP)
  • Purchase

    Common Stock

    [F10][F2]
    2020-11-05$15.32/sh+71,241$1,091,4121,268,374 total(indirect: By LP)
  • Purchase

    Common Stock

    [F11][F2]
    2020-11-05$23.79/sh+171,626$4,082,9831,440,000 total(indirect: By LP)
  • Purchase

    Common Stock

    [F12][F2]
    2020-11-05$20.78/sh+137,241$2,851,8681,577,241 total(indirect: By LP)
  • Purchase

    Common Stock

    [F13][F2]
    2020-11-05$20.94/sh+8,482$177,6131,585,723 total(indirect: By LP)
  • Purchase

    Common Stock

    [F14][F2]
    2020-11-06$20.63/sh+34,044$702,3281,619,767 total(indirect: By LP)
  • Purchase

    Common Stock

    [F15][F2]
    2020-11-06$22.33/sh+29,682$662,7991,649,449 total(indirect: By LP)
  • Purchase

    Common Stock

    [F16][F2]
    2020-11-06$23.48/sh+107,901$2,533,5151,757,350 total(indirect: By LP)
  • Purchase

    Common Stock

    [F17][F2]
    2020-11-06$23.87/sh+2,650$63,2561,760,000 total(indirect: By LP)
Footnotes (17)
  • [F1]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $10.11 to $11.00. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnotes 1 and 3 through 17 herein.
  • [F10]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.98 to $15.50.
  • [F11]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.09 to $24.00.
  • [F12]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.18 to $21.00.
  • [F13]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.86 to $21.00.
  • [F14]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $20.10 to $21.00.
  • [F15]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $21.85 to $22.84.
  • [F16]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $22.85 to $23.84.
  • [F17]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $23.85 to $23.87.
  • [F2]The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in a portion of the shares beneficially held by TCP.
  • [F3]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $12.88 to $13.44.
  • [F4]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.33 to $14.00.
  • [F5]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.18 to $14.00.
  • [F6]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.18 to $16.45.
  • [F7]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $16.33 to $17.00.
  • [F8]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $14.74 to $15.50.
  • [F9]The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.98 to $14.93.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION